Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Christine Fisher and Tyler Robin.
|
|
Connection Strength |
|
|
|
|
|
2.570 |
|
|
|
-
Robin TP, Amini A, Schefter TE, Behbakht K, Fisher CM. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy. Brachytherapy. 2016 Nov - Dec; 15(6):845-850.
Score: 0.563
-
Robin TP, Amini A, Schefter TE, Behbakht K, Fisher CM. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer. Gynecol Oncol. 2016 Nov; 143(2):319-325.
Score: 0.561
-
Shiao JC, Holt DE, Stuhr K, Schubert L, Robin T, Fisher CM. The Kelowna template for combined intracavitary and interstitial brachytherapy for gynecologic malignancies: Design, application, treatment planning, dosimetric and treatment outcomes. Brachytherapy. 2022 Nov-Dec; 21(6):823-832.
Score: 0.213
-
Shiao JC, Santoso A, Stuhr K, Bennett SJ, Gao D, Holt DE, Robin T, Fisher CM. Gynecologic interstitial brachytherapy curriculum using a low-cost phantom with ultrasound workshop and a treatment planning workshop is effective. Brachytherapy. 2022 Jan-Feb; 21(1):110-119.
Score: 0.201
-
Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clin Cancer Res. 2019 07 01; 25(13):3946-3953.
Score: 0.167
-
Zakem SJ, Robin TP, Smith DE, Amini A, Stokes WA, Lefkowits C, Fisher CM. Evolving trends in the management of high-intermediate risk endometrial cancer in the United States. Gynecol Oncol. 2019 03; 152(3):522-527.
Score: 0.166
-
Amini A, Robin TP, Rusthoven CG, Schefter TE, Akhavan D, Chen YJ, Glaser SM, Corr BR, Ashing KT, Fisher CM. Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer. Am J Clin Oncol. 2019 01; 42(1):21-26.
Score: 0.164
-
Stokes WA, Robin TP, Jackson MW, Amini A, Schefter TE, Lefkowits CC, Fisher CM. Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis. Am J Clin Oncol. 2018 10; 41(10):927-932.
Score: 0.162
-
Amini A, Robin TP, Stumpf PK, Rusthoven C, Schefter TE, Shinde A, Chen YJ, Glaser SM, Corr BR, Fisher CM. Rising Rates of Upfront Surgery in Early Locally Advanced Cervical Cancer: What Factors Predict for This Treatment Paradigm? Int J Gynecol Cancer. 2018 10; 28(8):1560-1568.
Score: 0.162
-
Robin TP, Grover S, Reddy Palkonda VA, Fisher CM, Gehl B, Bhattacharya K, Mallick I, Bhattasali O, Viswanathan AN, Sastri Chopra S, Mahantshetty U, Hardenbergh PH. Utilization of a Web-Based Conferencing Platform to Improve Global Radiation Oncology Education and Quality-Proof of Principle Through Implementation in India. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):276-280.
Score: 0.160
-
Ladbury C, Li R, Shiao J, Liu J, Cristea M, Han E, Dellinger T, Lee S, Wang E, Fisher C, Chen YJ, Amini A, Robin T, Glaser S. Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging? Gynecol Oncol. 2022 01; 164(1):39-45.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|